Table 1.
Variable | Description | |
---|---|---|
Volume | Gross tumor volume (cm3) | |
SUVmean | Mean SUV in the GTV | |
SUVmax | Maximum voxel SUV in the GTV | |
|
Fractional change in FLT SUVmean from pretreatment to midtreatment | |
|
Fractional change in FLT SUVmax from pretreatment to midtreatment | |
|
Fractional change in Cu-ATSM SUVmean from pretreatment to midtreatment | |
|
Fractional change in Cu-ATSM SUVmax from pretreatment to midtreatment | |
ρFDG,FLT | Spatial (voxel) correlation between pretreatment FDG and FLT uptake distributions | |
ρFDG,Cu-ATSM | Spatial (voxel) correlation between pretreatment FDG and Cu-ATSM uptake distributions | |
ρ FLT,Cu-ATSM | Spatial (voxel) correlation between pretreatment FLT and Cu-ATSM uptake distributions | |
|
Spatial (voxel) correlation between pretreatment and midtreatment FLT uptake distributions | |
|
Spatial (voxel) correlation between pretreatment and midtreatment Cu-ATSM uptake distributions |
Abbreviations: SUV = standardized uptake value; GTV = gross tumor volume; FLT = 3′-deoxy-3′-18F-fluorothymidine; Cu-ATSM = copper(II)-diacetyl-bis(N4-methylthiosemicarbazone); FDG = 2-deoxy-2-[18F]fluoro-D-glucose